𝔖 Bobbio Scriptorium
✦   LIBER   ✦

OM Group seeks precious metals partner


Publisher
Elsevier Science
Year
2003
Weight
32 KB
Volume
2003
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

✦ Synopsis


The outlook for 2002 is also included. Novozymes A/S is a biotech-based world leader in enzymes and microorganisms for industrial use. Novozymes also applies its core competences in selected pharmaceutical areas.


πŸ“œ SIMILAR VOLUMES


OM Group to sell precious metals group f
πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science βš– 33 KB

development and production of pharmaceutical intermediates. AHF integrates the introduction of versatile aldehyde functionality with the formation of a chiral centre. Dow's new generation of chiral bisphosphite ligands is claimed to expand the scope of the technology beyond the vinylarene substrates

OM precious metals sold to Umicore
πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science βš– 39 KB

working on a filamentous fungus named Trichoderma to engineer a metabolic pathway that breaks down biomass into monosaccharides. The biomass-to-ethanol conversion process technology would be economically competitive if the enzymes' cost were within the $0.05-0.15/gal of ethanol range. A pilot plant